APP

China Automotive Telematics Service Providers (TSP) and Application Services Research Report 2024: Next-Generation Application Service Platform will Build All-scenario Service Capabilities

Retrieved on: 
Thursday, February 29, 2024

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- The "Automotive Telematics Service Providers (TSP) and Application Services Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 29, 2024 /PRNewswire/ -- The "Automotive Telematics Service Providers (TSP) and Application Services Research Report, 2023-2024" report has been added to ResearchAndMarkets.com's offering.
  • Next how to provide diversified, personalized and intelligent application services using telematics big data will become the focus of major OEMs forging brand differentiation.
  • At present, China's intelligent connected vehicle application services are mainly four scenario services: in-vehicle information services, after-sales information services, off-vehicle near-field services and off-vehicle remote services.
  • Third, the next-generation application service platform will build all-scenario service capabilities covering intelligent driving, cockpit and connectivity.

ThriveAP and UPMC Enterprises Forge Groundbreaking Partnership with Growth Equity Infusion

Retrieved on: 
Wednesday, February 21, 2024

NASHVILLE, Tenn., Feb. 21, 2024 /PRNewswire-PRWeb/ -- ThriveAP, the industry-leading educational organization dedicated to advancing support and education for the advanced practice provider (APP) workforce and their employers, announces a transformative partnership with UPMC Enterprises, the innovation, commercialization, and venture capital arm of UPMC (University of Pittsburgh Medical Center). This strategic collaboration includes a significant growth equity infusion, marking a pivotal moment in ThriveAP's commitment to reshaping the landscape of healthcare education.

Key Points: 
  • This strategic collaboration includes a significant growth equity infusion, marking a pivotal moment in ThriveAP's commitment to reshaping the landscape of healthcare education.
  • Jim Creason, President, and CEO of ThriveAP, expressed his enthusiasm for the partnership, highlighting the collaborative efforts with the UPMC team.
  • "Working alongside the incredibly talented team at UPMC Enterprises, we've been able to strategize both immediate and long-term impacts that this substantial infusion will produce.
  • "The partnership between ThriveAP and UPMC Enterprises drives a better early career experience for APPs transitioning from an academic curriculum to patient care," said Ben Reynolds, Chief Advanced Practice Officer at UPMC.

USA Pickleball Grants Official Paddle Approval and Certification for OWL Paddles to be Used in all USAP Sanctioned Tournaments, Leagues and Events

Retrieved on: 
Wednesday, February 14, 2024

CHICAGO, Feb. 14, 2024 /PRNewswire/ -- The OWL pickleball paddle, an OWL Sport product, just received the USA Pickleball (USAP) certification that makes it 100% USAP tournament play-approved and certified for amateur and professional players to use at any event or competition in the world. The OWL is known for being the first USAP Quiet Category-certified paddle, delivering a 50% reduction in total noise profile while raising the bar on paddle performance. It was also announced that OWL is now an official paddle sponsor of the Association of Pickleball Players (APP), and currently the only one that reduces noise.

Key Points: 
  • It was also announced that OWL is now an official paddle sponsor of the Association of Pickleball Players (APP) , and currently the only one that reduces noise.
  • "We are honored to announce the OWL as an official APP paddle, building on our commitment to get more people playing pickleball more often."
  • "This partnership, coupled with our new USAP approval and certification, has positioned OWL to make an even bigger impact on the growing sport."
  • For more information on OWL Sport or to order the OWL paddle, visit owlpaddle.c om or follow @Owlpickleball on Facebook , Instagram , TikTok and X .

Scouting Settlement Trust to Advance Partial Payments to Survivors while Litigation is Pending

Retrieved on: 
Monday, February 12, 2024

Under the Advance Payment Program ("APP"), eligible claimants will be able to receive payments of $1,000 before their allowed claim amount is finally determined.

Key Points: 
  • Under the Advance Payment Program ("APP"), eligible claimants will be able to receive payments of $1,000 before their allowed claim amount is finally determined.
  • Eligibility to participate in the APP will be determined based upon a rigorous application of criteria to the information provided to the Scouting Settlement Trust (the "Trust") by individual claimants.
  • The Trust will – over time – make multiple payments on Survivors' claims as more funds are paid into the Trust and illiquid Trust assets are reduced to cash.
  • Litigation: The Trust also has litigation pending against dozens of insurance companies over billions of dollars more in coverage.

Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024

Retrieved on: 
Monday, February 12, 2024

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Jaya Biosciences, Inc. (“JayaBio” or “the Company”), a privately held early-stage life-sciences company developing CNS-directed gene therapies to address unmet needs in genetically defined neurodegeneration, reported non-clinical data at the 20th Annual WORLDSymposium™, a leading research conference on lysosomal diseases. During a late-breaking news platform presentation, Jaya Biosciences’ scientific founder, Prof. Mark Sands, reported preliminary human genetic analysis suggesting that heterozygous loss-of-function mutations in lysosomal enzyme genes are enriched in Alzheimer’s patients, as well as preclinical efficacy results in the animal model of Alzheimer’s disease (AD) for JB111, the Company’s lead therapy.

Key Points: 
  • “We are thrilled to showcase a new paradigm for the treatment of genetically defined neurodegeneration at the 20th WORLDSymposium™,” said Pawel Krysiak, President and CEO of JayaBio.
  • “The preclinical data we presented demonstrate a tremendous promise of targeting PPT1 haploinsufficiency in Alzheimer’s disease.
  • Heterozygosity of five different lysosomal enzyme genes (PPT1, NAGLU, GALC, IDUA, GUSB) significantly affects amyloid precursor protein (APP) processing and favors pro-amyloidogenic pathway.
  • CNS-directed, AAV-mediated gene therapy significantly increases the life span and improves cognitive function of 5xFAD/PPT1+/- mice.

Tineco's Valentine's Day Ideas for the Household

Retrieved on: 
Tuesday, February 6, 2024

Household chores are a very important and delicate topic between a couple, which could often become a cause for bickering.

Key Points: 
  • Household chores are a very important and delicate topic between a couple, which could often become a cause for bickering.
  • View the full release here: https://www.businesswire.com/news/home/20240206999582/en/
    Tineco's special offers for Valentine's Day (Photo: Business Wire)
    For dedicating to couple harmony on Valentine's Day, Tineco offers a series of floor cleaners on offer that guarantee precise cleaning.
  • Valentine's Day is the celebration of lovers, an opportunity to pamper your partner and express all your love.
  • A gift that a couple can give themselves, especially if they have recently lived together, is the TINECO FLOOR ONE S5.

Jiuxian Group: China's No.1 Liquor Enterprise announced new year goal of revenue 100 Billion Yuan

Retrieved on: 
Monday, February 5, 2024

At the beginning of 2024, Jiuxian, number one liquor circulation enterprise in China, announced the clear development goal: in the new era, a new starting point and a new journey, Jiuxian will adhere to high-quality development and start a new journey of "100 billion yuan".

Key Points: 
  • At the beginning of 2024, Jiuxian, number one liquor circulation enterprise in China, announced the clear development goal: in the new era, a new starting point and a new journey, Jiuxian will adhere to high-quality development and start a new journey of "100 billion yuan".
  • In the first livestreaming of Taobao liquor industry in last double 11, the livestreamer of Jiuxian Group in China, Jiuxian Liangge, achieved a pre-sale amount of 264 million, and secured the leading position.
  • Hao Hongfeng, the chairman of Jiuxian, reviewed the development of liquor brand agency business in 2001, liquor Internet retail in 2009, new offline retail in 2017, and livestreaming status in 2020.
  • Also, Jiuxian has also increased its investment in short videos, livestreaming and other marketing methods, and successfully won many leading livestreamers such as "Jiuxian Lafeige", "Jiuxian Liangge" and "Jiuxian Daliang".

In Case You Missed It: iFLYTEK Honored with the "Responsible Brand of the Year" Award at the 2023 Philanthropic Awards Ceremony

Retrieved on: 
Monday, February 5, 2024

BEIJING, Feb. 5, 2024 /PRNewswire/ -- On January 8, iFLYREC , iFLYTEK's cutting-edge multilingual simultaneous interpreting system, received the prestigious Responsible Brand of the Year award at the 2023 Philanthropic Awards Ceremony.

Key Points: 
  • BEIJING, Feb. 5, 2024 /PRNewswire/ -- On January 8, iFLYREC , iFLYTEK's cutting-edge multilingual simultaneous interpreting system, received the prestigious Responsible Brand of the Year award at the 2023 Philanthropic Awards Ceremony.
  • The conversion of spoken language into text addresses the needs of those with hearing impairment who may face challenges in directly comprehending verbal communication.
  • As of the end of 2023, "Hearing the Voice of AI" has delivered over 100 million minutes of free transliteration services to benefit the hearing-impaired.
  • iFLYREC remains committed to its social responsibility through concrete actions, employing technology to enhance the barrier-free living environment for the hearing-impaired.

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Retrieved on: 
Thursday, February 1, 2024

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer's disease.

Key Points: 
  • IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American: IGC) today announced additional positive results of preclinical studies investigating the Company's newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer's disease.
  • Previously disclosed results demonstrate that TGR-63 may successfully alleviate plaque burden in Alzheimer's cell lines and animal models.
  • In line with IGC Pharma's artificial intelligence and machine learning ("AI/ML") initiatives, we plan to leverage cutting-edge AI/ML tools for studying TGR-63's toxicology and protein interactions.
  • The results from these multiple tests indicate that TGR-63 treatment helped normalize emotional and behavioral responses in our Alzheimer's mouse model, reinforcing its potential as a promising treatment.

VAYK Updates Business Strategy to Concentrate On $64 Billion Domestic Short-Term Rental Market

Retrieved on: 
Thursday, February 1, 2024

The updated business strategy will refocus VAYK's short-term rental property business to within the continental USA.

Key Points: 
  • The updated business strategy will refocus VAYK's short-term rental property business to within the continental USA.
  • Previously, the overwhelming majority of VAYK's focus was concentrated on the international short-term rental property market with a tangible start-up presence primarily in the Caribbean.
  • The updated strategy will shift VAYK's focus to benefit from the fast-growing short-term rental market within the domestic USA, which is the largest short-term rental market in the world, having reached $64 billion in total sales, according to AirDnA .
  • VAYK is not a conventional short-term rental property management business.